Literatura científica selecionada sobre o tema "Sarcomatose multiple hémorragique de Kaposi – Thérapeutique"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Índice
Consulte a lista de atuais artigos, livros, teses, anais de congressos e outras fontes científicas relevantes para o tema "Sarcomatose multiple hémorragique de Kaposi – Thérapeutique".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Teses / dissertações sobre o assunto "Sarcomatose multiple hémorragique de Kaposi – Thérapeutique"
Gothland, Adélie. "La Primaquine, une thérapie innovante et ciblée pour les pathologies associées à l’infection par l’Herpèsvirus humain 8". Electronic Thesis or Diss., Sorbonne université, 2021. https://accesdistant.sorbonne-universite.fr/login?url=https://theses-intra.sorbonne-universite.fr/2021SORUS148.pdf.
Texto completo da fonteThe Human Herpesvirus 8 (HHV-8) is one of seven recognized human cancer causing viruses. HHV-8 is a principal causative agent of several human cancers including Kaposi’s sarcoma (KS), multicentric Castleman’s disease (MCD) and primary effusion lymphoma (PEL), which represent important and difficult to treat clinical problem, with very few therapeutic options. In the present in vitro study, we demonstrated the specific cytotoxic and pro-apoptotic effect of the antimalarial primaquine disphosphate in HHV-8-infected PEL cells, without any toxicity on different uninfected cells. We also found that primaquine-induced oxidative stress and pro-apoptotic UPR activated by excessive reticulum endoplasmic stress, to be part of the pro-apoptotic mechanisms of action of primaquine in PEL cells. Finally, PQ treatment had a clinical positive effect on tumor growth in a in vivo NOD/SCID xenograft PEL mouse model, as well as in a pilot clinical study in human harboring very severe KS. Importantly, primaquine was well tolerated and none adverse event and overt toxic effects were observed in both primaquine-treated mice and patients. The combination of preclinical and clinical observations and results from our analysis thereby raising the possibility that primaquine may be used as a promising targeted agent in treatment of HHV-8-associated cancers
Diagne, Baba. "Radiothérapie du sarcome de kaposi : à propos de 21 patients traités à la Fondation Bergonié". Bordeaux 2, 1992. http://www.theses.fr/1992BOR2M096.
Texto completo da fonteMichéa, Pascal. "La maladie de Kaposi bronchopulmonaire". Montpellier 1, 1996. http://www.theses.fr/1996MON11014.
Texto completo da fonteBoralevi, Franck. "Huitième virus herpès humain (HHV-8) et maladie de Kaposi : une étude d'épidémiologie moléculaire menée sur 48 cas". Bordeaux 2, 1999. http://www.theses.fr/1999BOR23075.
Texto completo da fonteGuillot, Armelle. "La maladie de Kaposi". Paris 5, 2001. http://www.theses.fr/2001PA05P008.
Texto completo da fonteCaporini, Marie-Laure. "Le sarcome de Kaposi chez la femme dans le cadre du sida : à propos de deux cas". Bordeaux 2, 1994. http://www.theses.fr/1994BOR2M004.
Texto completo da fonteTarte, Karin. "Immunothérapie du myélome multiple". Montpellier 1, 1999. http://www.theses.fr/1999MON13515.
Texto completo da fonteNouts, Caroline. "Les manifestations extra-cutanées de la maladie de Kaposi au cours du sida : analyse rétrospective de 80 observations". Bordeaux 2, 1995. http://www.theses.fr/1995BOR23066.
Texto completo da fonteWirden, Marc. "PCR quantitative en temps réel du 8ème herpesvirus humain". Paris 5, 1999. http://www.theses.fr/1999PA05P191.
Texto completo da fontePinto, Roselyne. "Les manifestations bucco-faciales du syndrome d'immunodéficience acquise (SIDA) et leurs traitements". Paris 5, 1994. http://www.theses.fr/1994PA05P036.
Texto completo da fonte